NCT07044180View on ClinicalTrials.gov

Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 26, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Neuromuscular Blocking AgentsResidual Neuromuscular BlockReversal of Neuromuscular Blockade
Interventions
DRUG

pipecuronium bromide

Investigation of muscle relaxation with pipecuronium bromide

DRUG

Rocuronium bromide

Muscle relaxation with rocuronium as a control

Trial Locations (1)

4032

University of Debrecen, Department of Anesthesiology and Intensive Care, Debrecen

All Listed Sponsors
lead

Tamas Vegh, MD

OTHER